Julie Holder

 Julie Holder
Julie Holder
Head of iPSC Innovation
Roslin Cells

Presentations at Drug Discovery 2015

Wed2  Sep03:00pm(30 mins)
Efficacy and Toxicity Assays Using iPS cells - Utilising Cells Reset to the Manufacturers Default Setting

Session: Innovation in Assay Development & Screening
Room: To be announced

Profile of Julie Holder

Dr Julie Holder is currently the Head of iPSC Innovation at Roslin Cells and is Head of facility at Cambridge, UK. Julie joined Roslin Cells after 26 years of working in the Pharmaceutical Industry and brings a knowledge of target validation, screening, primary assay development and in vivo experimental work with small molecules and Biopharmaceuticals. During her time in the Pharmaceutical Industry Julie has worked in both Drug Discovery and Preclinical Toxicology Departments and has been privileged to work on compounds at all stages of development in disease areas such as Diabetes, Respiratory, Neuroscience and Inflammation.


Mr Nicholas Clare
iPSC Operational Lead
Roslin Cells
Poster Presenter
Dr Daniel Tams
iPSC Scientist
Roslin Cells
Please login to send a Private Message

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018